VB
Vikram Bery
About Vikram Bery
Data last updated:
Vikram Bery is a Director at Apogen Remedies Private Limited (since 2019), Director at Bago Laboratories Private Limited (since 2008) and Additional Director at Shangrila Intermediaries Private Limited (since 2014). The companies operate in Pharma and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹9.08 Cr; the largest is Apogen Remedies Private Limited at ₹8.63 Cr (FY 2025). Earlier, Vikram Bery was a Partner at Exarmed Pharma Llp (2024) and Director at Alphamed Formulations Private Limited (2012–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apogen Remedies Private Limited U24232TG2011PTC075363 | Director | 19 Jul 2019 | 2011 | ₹8.63 Cr (FY 2025) | Active |
 Bago Laboratories Private Limited U24239TG2002PTC038340 | Director | 01 May 2008 | 2002 | ₹44.2 Lakh (FY 2025) | Active |
| Shangrila Intermediaries Private Limited U24239TG2004PTC043270 | Additional Director | 23 Dec 2014 | 2004 | ₹64,132 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Exarmed Pharma Llp ACI-6222 | Partner | 27 Jul 2024 | 2024 | Active | |
 Alphamed Formulations Private Limited U24239TG2006PTC051732 | Director | 26 Sep 2012 | 2006 | ₹197 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vikram Bery
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhishek Shukla | Apogen Remedies Private Limited | Company Secretary | |
| Bala Murali Krishna Thippabhotla | 02166860 | Apogen Remedies Private Limited , Bago Laboratories Private Limited | Director |
| Bhanu Prasad Kommineni | 01408377 | Apogen Remedies Private Limited | Director |
| Tamma Raghava Srinivasa Reddy | 02509720 | Apogen Remedies Private Limited | Director |
| Neeraja Thippabhotla | 00875340 | Shangrila Intermediaries Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikram Bery
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikram Bery
Vikram Bery currently holds 3 directorships: Apogen Remedies Private Limited (Director, since 19 Jul 2019, revenue ₹8.63 Cr (FY 2025)); Bago Laboratories Private Limited (Director, since 01 May 2008, revenue ₹44.2 Lakh (FY 2025)); Shangrila Intermediaries Private Limited (Additional Director, since 23 Dec 2014, revenue ₹64,132 (FY 2025)).
Vikram Bery was first appointed on 01 May 2008 as Director at Bago Laboratories Private Limited. The most recent appointment on record is 27 Jul 2024 at Exarmed Pharma Llp.
The 3 current companies of Vikram Bery that report revenue have a combined latest revenue of ₹9.08 Cr: Apogen Remedies Private Limited ₹8.63 Cr (FY 2025); Bago Laboratories Private Limited ₹44.2 Lakh (FY 2025); Shangrila Intermediaries Private Limited ₹64,132 (FY 2025).
Vikram Bery held 2 earlier board appointments: Exarmed Pharma Llp (Partner, 27 Jul 2024 to 12 Aug 2024); Alphamed Formulations Private Limited (Director, 26 Sep 2012 to 12 Jun 2018).
The current boards of Vikram Bery's companies include Abhishek Shukla (Apogen Remedies Private Limited), Bala Murali Krishna Thippabhotla (Apogen Remedies Private Limited), Bhanu Prasad Kommineni (Apogen Remedies Private Limited), Tamma Raghava Srinivasa Reddy (Apogen Remedies Private Limited), Neeraja Thippabhotla (Shangrila Intermediaries Private Limited).